Product Ref: MBPUR01 Category: P
Royal Mail Tracked 24 (Signed For)
Royal Mail Special Delivery Guaranteed by 1pm
Category | POM-V |
Temperature | Refrigerated |
MA/VM/EU No: | 04491/5054 |
Species |
|
VMD Link | https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_2324680.PDF |
NOAH Link | |
Dosage | Amounts to be administered and administration route Subcutaneous route. Reconstitute gently the vaccine in order to obtain a uniform suspension with limited foam formatino. Visual appearance after reconstitution: slightly yellow suspension with presence of cell debris in suspension. After reconstitution of the lyophilisate with 0.5 ml or 10 ml of the solvent (depending on the presentation chosen), inject one dose of vaccine according to the following vaccination scheme: Primary vaccination course: -First injection from 8 weeks of age -Second injection 3 to 4 weeks later Where high levels of maternal antibodies against rhinotracheitis, calicivirosis or panleucopenia components are expected to be present (e.g. in kittens of 9-12 weeks of age borne from queens which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age. Revaccination: -The first revaccination must be carried out for all components one year after the primary vaccination course, -Subsequent revaccinations: Feline leukaemia component: every year. Rhinotracheitis, calicivirosis and panleucopenia components: at intervals of up to three years. Overdose No effect other than those already mentioned under Adverse reactions have been observed, except hyperthermia that may exceptionally last 5 days. |
Withdrawals |